10 Mar 09
Job satisfaction is an attitude that employees have about their work and is based on numerous factors, both intrinsic and extrinsic to the individual. Job satisfaction is important from the perspective of maintaining and retaining the appropriate employees within the organization; it is about fitting the right person to the right job in the right culture and keeping them satisfied.
Toni Lakin - Phlexglobal Ltd
28 Nov 08
âMore universities should provide courses that offer hands-on experience to better prepare their students.â This is the response from the Head of Cranfield Health, Professor Joe Lunec, after a report claimed that those leaving universities lacked the required knowledge and skills to progress in the UKâs pharmaceutical industry.
26 Nov 08
Our eMarketing team at PharmiWeb Solutions often works with pharma brand teams to find new ways to reach healthcare professionals with news of the latest product or initiative. And sometimes, it can be challenging, with all of the pressures and time constraints that the average primary care practice faces.
14 Nov 08
The UKâs success as a global centre of biomedical excellence is under threat in the long-term. A new report by the Association of the British Pharmaceutical Industry (ABPI) has highlighted serious concerns about the supply of skills that support the research and development of new medicines.
20 Oct 08
The ever-evolving healthcare industry has very few constants, and the pharmaceutical sales industry is just another piece of the puzzle that is in the middle of a major transformation. For multinationals, eager to sell their drugs in different countries, juggling between scores of different languages and different laws has always proved to be a major dampener.
14 Oct 08
The pharmaceutical industry has often been described as counter-recessionary, the broad logic being that people will always get sick, and hence there will be a continuous demand for drugs. And whilst this may be true at a surface level, a more granular analysis would reveal dissimilarities between different segments of the industry
19 Sep 08
If you are new to using PharmiWeb.com in your job searching, you'll soon realise that we have thousands of jobs listed and that they change every day. This means you may initially find the task a bit daunting.
02 Sep 08
With these increasing pressures upon the pharmaceuticals industry, it has never been more important to formulate an accurately informed pricing strategy
27 Aug 08
Whether you are looking for pharma sales jobs, clinical research jobs, or any other pharmaceutical job, with thousands of jobs in the PharmiWeb.com database you can be forgiven for not coming back every day to search... Well, you actually dont have to - we can do the searching for you!
17 Jun 08
Cimzia (certolizumab pegol) is the first and so far, only, PEGylated, Fc-Free, anti-tumour necrosis factor (TNF) alpha treatment in development for rheumatoid arthritis. Data presented at the Annual European Rheumatology Congress (EULAR) suggest that, in combination with methotrexate, Cimzia acts fast to significantly suppress disease activity, prevent structural damage to joints, preserve physical function and help patients continue working productively.
Olwen Glynn Owen - Pharmiweb Field reporter
29 May 08
10 simple points to remember when writing a great CV. Your CV is the first point of contact between you and a prospective new employer. It is unlikely that the reader will know anything about you except whatâs in the CV â so try to see it from their perspective.
29 May 08
A great summary of points to remember when writing your job application covering letter. The main purpose of a covering letter is to present your CV in support of your job application. This may be obvious, but itâs surprising how many people appear to think that a covering letter needs to be long and complicated and somehow justify its own existence..
21 May 08
We have an enviable position of being visited by over 150,000 people each month looking for pharmaceutical news and jobs, and we need to satisfy their desire for content.
13 May 08
In 2007, blood diseases cost the USâs economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively. From oxygen delivery to immunological defence to clotting, blood has vital physiological functions, and clear, expensive treatments.
09 May 08
âBy 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, research has foundâ. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.
Nini Wei- Visiongain Ltd
06 May 08
The ins and outs of the daily life for Medical Sales Reps.
11 Apr 08
Which current or future therapies will drive the sleep disorders market from 2008 to 2018?
What is the patient identification rate for each of the therapeutic areas?
What is the present state of the disease awareness?
What R&D opportunities exist for ânew comersâ?
Which key companies are involved in the market?
01 Apr 08
Forget sweat patches, VPLs and spotsâŚa new survey commissioned by KleenexÂŽ has found that itâs blowing your nose in public that causes us the most embarrassment! The survey of hay fever sufferers reveals that most people prefer a quiet sniff over a good nose blow when out and about. However, allergy specialists warn that the more discreet option actually makes symptoms worse.
31 Mar 08
Asthma is a significant health problem. Acording to the National Asthma Campaign, the condition continues to grow, and in the UK an estimated 8 million people are diagnosed as having asthma, with 5 million people receiving treatment. The cost of asthma to the NHS is more than ÂŁ850 million a year.
25 Mar 08
Bell Pottinger Group has formed Bell Pottinger Health, a new business dedicated to leading the expansion of its health franchise with Shipra Singh newly hired as Managing Director. Simultaneously the company has brought in a life science investor relations team led by Mike Wort.
12 Mar 08
Research led by the University of Warwick has uncovered exactly how the bacterium Streptococcus pneumoniae has become resistant to the antibiotic penicillin. The same research could also open up MRSA to attack by penicillin and help create a library of designer antibiotics to use against a range of other dangerous bacteria.
04 Dec 07
Spanish pharmaceutical company Almirall has unveiled a state-of-the-art new dry-powder inhaler in which it plans to market its lead pipeline compound aclidinium bromide for chronic obstructive pulmonary disease (COPD). The device, developed by specialist inhaler company Sofotec, acquired by Almirall in 2006, is set to become the gold standard in inhaler design, claims the company, and will aid patient compliance with anticholinergic medication.
Olwen Glynn Owen - Pharmiweb Field Reporter